Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
OSK

Oshkosh

$75.07

-1.03 (-1.35%)

, SQ

Square

$69.09

-12.06 (-14.86%)

10:19
08/02/19
08/02
10:19
08/02/19
10:19
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

OSK

Oshkosh

$75.07

-1.03 (-1.35%)

SQ

Square

$69.09

-12.06 (-14.86%)

ADAP

Adaptimmune

$2.62

-0.335 (-11.34%)

HGV

Hilton Grand Vacations

$26.69

-1.43 (-5.09%)

VAL

Valaris

$6.27

-0.505 (-7.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 10

    Sep

  • 06

    Nov

ADAP

Adaptimmune

$2.96

-0.345 (-10.45%)

07:13
08/02/19
08/02
07:13
08/02/19
07:13
Downgrade
Adaptimmune rating change at Guggenheim »

Adaptimmune downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADAP

Adaptimmune

$2.96

-0.345 (-10.45%)

20:23
08/01/19
08/01
20:23
08/01/19
20:23
Downgrade
Adaptimmune rating change at Guggenheim »

Adaptimmune downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

ADAP

Adaptimmune

$3.30

(0.00%)

07:57
08/01/19
08/01
07:57
08/01/19
07:57
Hot Stocks
Adaptimmune promotes John Lunger to chief patient supply officer »

Adaptimmune Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

ADAP

Adaptimmune

$3.30

(0.00%)

07:31
08/01/19
08/01
07:31
08/01/19
07:31
Hot Stocks
Adaptimmune sees cash, cash equivalents funding operations through 3Q20 »

The Company believes that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

ADAP

Adaptimmune

$3.30

(0.00%)

07:30
08/01/19
08/01
07:30
08/01/19
07:30
Earnings
Adaptimmune reports Q2 EPS (7c), consensus (33c) »

Reports Q2 revenue $0.2M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

ADAP

Adaptimmune

$3.30

0.18 (5.77%)

04:55
07/31/19
07/31
04:55
07/31/19
04:55
Conference/Events
Adaptimmune management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 01

    Aug

ADAP

Adaptimmune

$3.12

-0.05 (-1.58%)

04:55
07/30/19
07/30
04:55
07/30/19
04:55
Conference/Events
Adaptimmune management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 31

    Jul

  • 01

    Aug

ADAP

Adaptimmune

$3.17

0.15 (4.97%)

04:55
07/29/19
07/29
04:55
07/29/19
04:55
Conference/Events
Adaptimmune management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

  • 29

    Jul

  • 30

    Jul

  • 31

    Jul

ADAP

Adaptimmune

$3.17

0.15 (4.97%)

04:55
07/29/19
07/29
04:55
07/29/19
04:55
Recommendations
Adaptimmune analyst commentary  »

Adaptimmune management to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

  • 29

    Jul

  • 30

    Jul

  • 31

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.